Cancer

Breast Cancer Screening: Why Starting Mammograms at 40 Could Save More Lives

Breast Cancer Screening: Why Starting Mammograms at 40 Could Save More Lives

When should women start getting mammograms, and how often should they have them? These are important questions because finding breast cancer early can make treatment more successful. Research published in JAMA suggests that starting regular breast cancer screening at age 40, rather than waiting until 50, could help prevent more deaths. The findings also show why...

The Hidden Long-Term Effects of Chemotherapy in Older Breast Cancer Survivors

The Hidden Long-Term Effects of Chemotherapy in Older Breast Cancer Survivors

Thanks to advances in breast cancer treatment, more women are living longer after their diagnosis than ever before. But as survival rates improve, researchers are paying closer attention to what happens after treatment ends. For many survivors, the effects of chemotherapy do not disappear when the last infusion is completed. A recent study examined older breast...

Physical Activity and Cancer Survival: Why Moving More May Be One of the Most Powerful Tools After a Cancer Diagnosis

Physical Activity and Cancer Survival: Why Moving More May Be One of the Most Powerful Tools After a Cancer Diagnosis

For many years, exercise was viewed primarily as a way to improve fitness and overall health. Today, researchers are discovering that physical activity may play a much larger role in cancer care. A growing body of evidence suggests that regular exercise can improve quality of life, reduce treatment-related side effects, and may even help people live longer after a...

A Hidden Subtype of Endometrial Cancer – What Subtypes Mean for Cancer Care

A Hidden Subtype of Endometrial Cancer – What Subtypes Mean for Cancer Care

A new systematic review and meta-analysis is helping shine a spotlight on one of the least understood groups: high-grade endometrioid endometrial cancers with no specific molecular profile (NSMP). The findings suggest that this subtype represents nearly one-third of high-grade endometrial cancers and may play an important role in the future of personalized cancer care.